Axel Witt

Axel Witt, Dr. has extensive experience in the fields of medical affairs and life sciences, currently serving as the International Medical Affairs Manager at Neovii since November 2020. In this role, Axel Witt oversees the implementation of global medical strategies across various therapy areas, including hematology and oncology, while fostering relationships with medical experts and leading clinical trials. Prior to Neovii, Axel Witt was a Postdoctoral Research Scientist at Genentech, focusing on inflammatory diseases and immunology, and held research fellow positions at CECAD Cologne, where projects examined tumor cell adaptations, and at Uniklinik Köln, contributing to a deeper understanding of tumor growth mechanisms. An accomplished academic, Axel Witt holds a PhD in Molecular Biology and Genetics from the University of Cologne and is currently pursuing an Executive MBA at the Quantic School of Business and Technology.